Treatment of Human Viral Infections Read more about Treatment of Human Viral Infections US Application 60/587,810Filed on 2004-07-13
Treatment of Human Viral Infections Read more about Treatment of Human Viral Infections US Application 60/588,013Filed on 2004-07-13
Modulating MxA Expression Read more about Modulating MxA Expression US Application 60/613,371Filed on 2004-09-27
Methods and Compositions Related to the Inhibitors of HIV using RNase H Inhibitors Read more about Methods and Compositions Related to the Inhibitors of HIV using RNase H Inhibitors US Application 60/605,165Filed on 2004-08-30
Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies Read more about Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies US Application 60/623,394Filed on 2004-10-29
Methods of Reducing the Activity of and Reducing the Concentration of an Eph Receptor Tyrosine Kinase Read more about Methods of Reducing the Activity of and Reducing the Concentration of an Eph Receptor Tyrosine Kinase US Application 60/591,986Filed on 2004-07-29
DNA-Based Vaccination of Retroviral-Infected Individuals Undergoing Treatment Read more about DNA-Based Vaccination of Retroviral-Infected Individuals Undergoing Treatment US Application 60/586,539Filed on 2004-07-09
A Novel Antiproliferative Factor And Methods Of Use In Interstitial Cystitis Read more about A Novel Antiproliferative Factor And Methods Of Use In Interstitial Cystitis US Application 60/569,363Filed on 2004-05-08
COMPLETE CHARACTERIZATION AOF AN ANTIPROLIFERATIVE FACTOR FROM BLADDER EPITHELIAL CELLS OF INTERSTITIAL CYSTITIS PATIENTS Read more about COMPLETE CHARACTERIZATION AOF AN ANTIPROLIFERATIVE FACTOR FROM BLADDER EPITHELIAL CELLS OF INTERSTITIAL CYSTITIS PATIENTS US Application 60/515,850Filed on 2003-10-30
The UBE2G2 Binding Domain in the Ubiquitin Ligase GP78 and Methods of Use Thereof Read more about The UBE2G2 Binding Domain in the Ubiquitin Ligase GP78 and Methods of Use Thereof US Application 60/583,263Filed on 2004-06-26